These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors: modifications of a tripeptide analogue. Meyer RF; Essenburg AD; Smith RD; Kaplan HR J Med Chem; 1982 Aug; 25(8):996-9. PubMed ID: 6288947 [TBL] [Abstract][Full Text] [Related]
4. Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion. Almquist RG; Crase J; Jennings-White C; Meyer RF; Hoefle ML; Smith RD; Essenburg AD; Kaplan HR J Med Chem; 1982 Nov; 25(11):1292-9. PubMed ID: 6292422 [TBL] [Abstract][Full Text] [Related]
5. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats. Takata Y; Di Nicolantonio R; Hutchinson JS Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats. Baum T; Becker FT; Sybertz EJ Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of pentapeptide analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. Almquist RG; Jennings-White C; Chao WR; Steeger T; Wheeler K; Rogers J; Mitoma C J Med Chem; 1985 Aug; 28(8):1062-6. PubMed ID: 2991517 [TBL] [Abstract][Full Text] [Related]
8. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. Almquist RG; Chao WR; Jennings-White C J Med Chem; 1985 Aug; 28(8):1067-71. PubMed ID: 2991518 [TBL] [Abstract][Full Text] [Related]
11. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322 [TBL] [Abstract][Full Text] [Related]
12. Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration. Bhuyan BJ; Mugesh G Org Biomol Chem; 2011 Jul; 9(14):5185-92. PubMed ID: 21629912 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep. Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389 [TBL] [Abstract][Full Text] [Related]